Bank of Montreal (TSX:BMO; NYSE:BMO) continued its downward drift on Thursday, with shares slipping 0.9% to $174.09 by mid-morning. The decline follows a sharper 3.75% drop in the previous session, as market participants reassess the stock's valuation ahead of its fiscal third-quarter earnings report, scheduled for August 25.
The New York-listed shares traded within a range of $173.33 to $175.77 by 10:47 AM EDT, reflecting persistent selling pressure. The recent slide comes despite renewed attention on institutional buying activity, but market observers caution that the headlines may be misleading.
Institutional Filings: A Lagging Indicator
Recent regulatory filings have highlighted positions held by Tacita Capital, Deutsche Bank (ETR:DBK), and K.J. Harrison & Partners. However, these disclosures represent holdings as of the end of the previous quarter, not current trading activity. For instance, Deutsche Bank reported owning 1,334,415 BMO shares as of June 30, an increase of 31,851 shares from the prior quarter. While that represents a 2.4% quarterly rise, it amounts to only about 0.19% of BMO's total outstanding shares, and the increase itself is a mere 0.005% of the company.
"These filings describe past positions, not today's demand," noted a market strategist. "Investors should focus on more current signals, such as earnings and valuation."
Analyst Sentiment Remains Cautious
The analyst community is largely treading water. Fourteen analysts currently rate the stock as a Hold, with only four positive ratings (two Strong Buys and two Buys) and three negative (two Sells and one Strong Sell). The average analyst target price stands at $166.21, which is 4.5% below Thursday's live price, suggesting limited upside potential in the near term.
On Thursday, Bank of America (NYSE:BAC) analyst Ebrahim Poonawala raised his price target on BMO to $188 from $177, but maintained a Hold rating. Earlier in the week, CIBC (TSX:CM) analyst Paul Holden downgraded BMO to Hold, citing valuation concerns after the stock's recent rally.
Valuation and Earnings in Focus
BMO currently trades 7.0% below its 52-week high of $187.22, yet the consensus target implies a discount to the market price. This disconnect highlights the market's uncertainty about the bank's near-term prospects. The upcoming earnings report on August 25 will be a critical catalyst, with investors focusing on U.S. credit quality, net interest margins, and capital deployment.
In the second quarter, BMO reported strong results: net income rose 34% year-over-year to C$2.63 billion, and earnings per share climbed 41% to C$3.53. Credit-loss provisions fell 30% to C$739 million, and return on equity improved to 13.0% from 9.4%. However, the common-equity Tier 1 (CET1) ratio slipped to 13.0% from 13.5% a year earlier, as internal capital generation didn't fully offset buybacks and higher risk-weighted assets.
What to Watch
Investors will be watching whether BMO can sustain its momentum in commercial loan growth, which CEO Darryl White described as "solid" in both Canada and the U.S. However, margins, U.S. credit performance, and capital usage will be key tests. If the bank delivers better-than-expected credit metrics or raises guidance, today's valuation caution could prove premature. Conversely, any deterioration in the U.S. loan book or a further decline in capital ratios would likely reinforce bearish sentiment.
With the earnings date just five days away, the market's attention is firmly on the fundamental picture rather than the noise of institutional filings.
